- $12.27bn
- $11.88bn
- $1.56bn
- 95
- 21
- 99
- 83
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 758 | 984 | 1,270 | 1,388 | 1,562 |
Cost of Revenue | |||||
Gross Profit | 563 | 671 | 781 | 861 | 1,049 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 839 | 1,183 | 1,595 | 1,673 | 1,586 |
Operating Profit | -81.6 | -199 | -326 | -285 | -24.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -85.2 | -152 | -53 | -468 | 37.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -87.7 | -167 | -117 | -425 | 33.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -87.7 | -167 | -117 | -425 | 33.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -87.7 | -167 | -117 | -425 | 33.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.58 | -2.81 | -1.7 | -6.99 | 1.06 |